Thus, it is highly probable that since ovarian cancer shows high levels of Cdk1 expression and activity, ovarian cancer could exhibit resistance to DNA damage agents due to increased BRCA activity by Cdk1. The gene discussed is CDK1; the disease is ovarian carcinoma.